Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Lenvima
Lenvima
ESMO: Merck, Eisai detail Keytruda-Lenvima combo results after triple endometrial cancer OK
ESMO: Merck, Eisai detail Keytruda-Lenvima combo results after triple endometrial cancer OK
Fierce Pharma
Merck
Eisai
Keytruda
Lenvima
endometrial cancer
ESMO
Flag link:
Merck, Eisai's Keytruda-Lenvima combo wins simultaneous OKs in U.S., Canada and Australia
Merck, Eisai's Keytruda-Lenvima combo wins simultaneous OKs in U.S., Canada and Australia
Fierce Pharma
Merck
Keytruda
Eisai
Lenvima
endometrial cancer
Canada
Australia
Flag link:
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
CP Wire
China
Eisai
Merck
Lenvima
liver cancer
HCC
Flag link:
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
Eisai
Merck
Lenvima
liver cancer
hepatocellular carcinoma
Flag link:
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
CP WIre
Eisai
Merck
Lenvima
hepatocellular carcinoma
Europe
Flag link:
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
Eisai
Merck
Lenvima
hepatocellular carcinoma
Flag link:
Eisai-Merck partnership picks up first-line Lenvima approval
Eisai-Merck partnership picks up first-line Lenvima approval
Biopharma Dive
FDA
Eisai
Merck
Lenvima
hepatocellular carcinoma
Flag link:
Japan's Eisai sets price tag of about $16,000 on liver cancer drug
Japan's Eisai sets price tag of about $16,000 on liver cancer drug
Yahoo/Reuters
Eisai
liver cancer
drug pricing
Lenvima
Flag link:
Eisai's Lenvima posts big growth numbers as Merck collaboration rolls into action
Eisai's Lenvima posts big growth numbers as Merck collaboration rolls into action
Fierce Pharma
Merck
Eisai
Lenvima
kidney cancer
thyroid cancer
Flag link:
FDA stalls Eisai—and its new partner Merck—in quest to widen cancer med Lenvima's reach
FDA stalls Eisai—and its new partner Merck—in quest to widen cancer med Lenvima's reach
Fierce Pharma
Merck
Eisai
Lenvima
liver cancer
FDA
Flag link:
Doubling down on the Keytruda franchise, Merck pays $300M and promises $5B-plus to partner with Eisai on its budding cancer star
Doubling down on the Keytruda franchise, Merck pays $300M and promises $5B-plus to partner with Eisai on its budding cancer star
Endpoints
Merck
Keytruda
Eisai
Lenvima
Flag link:
Merck & Co. and Eisai seek to undermine BMS’ position in kidney cancer treatment sector
Merck & Co. and Eisai seek to undermine BMS’ position in kidney cancer treatment sector
GoinPharma
Eisai
Merck
Bristol-Myers Squibb
kidney cancer
Keytruda
Lenvima
Opdivo
Flag link:
Merck, Eisai nab Keytruda-Lenvima 'breakthrough' in quickly crowding kidney cancer field
Merck, Eisai nab Keytruda-Lenvima 'breakthrough' in quickly crowding kidney cancer field
Fierce Pharma
Merck
Eisai
Keytruda
Lenvima
kidney cancer
Flag link:
Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar
Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar
Fierce Pharma
Eisai
Lenvima
liver cancer
Bayer
Nexavar
ASCO 2017
Flag link:
Eisai's kidney drug wins expanded indication in the U.S.
Eisai's kidney drug wins expanded indication in the U.S.
BioPharma Dive
Eisai
advanced renal cell carcinoma
kidney cancer
Lenvima
RCC
Flag link:
Eisai scores FDA priority review for bigger Lenvima use in kidney cancer
Eisai scores FDA priority review for bigger Lenvima use in kidney cancer
Fierce Pharma
Eisai
Lenvima
kidney cancer
FDA
priority review
Flag link:
Eisai's launch for 'crown jewel' Lenvima tracking better than execs expected
Eisai's launch for 'crown jewel' Lenvima tracking better than execs expected
Fierce Pharma Marketing
Eisai
Lenvima
thyroid cancer
Flag link:
Eisai Says New Cancer Drug Reaching Patients Faster Than Planned
Eisai Says New Cancer Drug Reaching Patients Faster Than Planned
Bloomberg
Eisai
patients
Lenvima
thyroid cancer
Flag link:
Eisai gets EMA nod for Lenvima just weeks after FDA approval
Eisai gets EMA nod for Lenvima just weeks after FDA approval
Fierce Pharma
Eisai
FDA
Lenvima
thyroid cancer
Flag link:
Can Eisai pump its thyroid cancer pill to $1B in sales? Rival Bayer might object
Can Eisai pump its thyroid cancer pill to $1B in sales? Rival Bayer might object
Fierce Pharma Marketing
Eisai
Bayer
thyroid cancer
Lenvima
Nexavar
Flag link:
Pages
1
2
next ›
last »